Guard Therapeutics International AB (GUARD)

Currency in SEK
22.40
-0.60(-2.61%)
Real-time Data·
GUARD Scorecard
Full Analysis
Significant return over the last week
Earnings results expected in 13 days
GUARD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.3023.20
52 wk Range
11.8534.80
Key Statistics
Prev. Close
23
Open
23
Day's Range
22.3-23.2
52 wk Range
11.85-34.8
Volume
26K
Average Volume (3m)
35.82K
1-Year Change
-20.14%
Book Value / Share
4.66
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GUARD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Guard Therapeutics International AB Company Profile

Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.

Compare GUARD to Peers and Sector

Metrics to compare
GUARD
Peers
Sector
Relationship
P/E Ratio
−4.0x−9.5x−0.5x
PEG Ratio
0.30−0.200.00
Price/Book
8.2x6.6x2.6x
Price / LTM Sales
-42.0x3.3x
Upside (Analyst Target)
96.0%10.1%43.4%
Fair Value Upside
Unlock6.0%7.1%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-2.78 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

GUARD Income Statement

FAQ

What Stock Exchange Does Guard Therapeutics Trade On?

Guard Therapeutics is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Guard Therapeutics?

The stock symbol for Guard Therapeutics is "GUARD."

What Is the Guard Therapeutics Market Cap?

As of today, Guard Therapeutics market cap is 451.75M.

What Is Guard Therapeutics's Earnings Per Share (TTM)?

The Guard Therapeutics EPS (TTM) is -9.89.

When Is the Next Guard Therapeutics Earnings Date?

Guard Therapeutics will release its next earnings report on 20 Aug 2025.

From a Technical Analysis Perspective, Is GUARD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Guard Therapeutics Stock Split?

Guard Therapeutics has split 10 times.

How Many Employees Does Guard Therapeutics Have?

Guard Therapeutics has 12 employees.

What is the current trading status of Guard Therapeutics (GUARD)?

As of 08 Aug 2025, Guard Therapeutics (GUARD) is trading at a price of 22.40, with a previous close of 23.00. The stock has fluctuated within a day range of 22.30 to 23.20, while its 52-week range spans from 11.85 to 34.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.